Moreover, analysis of sarcosine metabolism phenotype revealed that patients with sarcosine-high type [GNMT(+)/SARDH and PIPOX(-)] tumors had a shorter DFS than patients with other breast cancer tumor types, suggesting that sarcosine level is a prognostic factor in breast cancer. This evidence concerns the gene SARDH and breast carcinoma.